These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 3874906)

  • 1. Preferential generation of human T cell hybrids with a tetraploid fusion partner.
    Berger AE; Kuentzel SL; Davidson SO
    J Immunol; 1985 Sep; 135(3):1792-9. PubMed ID: 3874906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inheritance of immunogenicity and metastatic potential in murine cell hybrids from the T-lymphoma ESb08 and normal spleen lymphocytes.
    Larizza L; Schirrmacher V; Stöhr M; Pflüger E; Dzarlieva R
    J Natl Cancer Inst; 1984 Jun; 72(6):1371-81. PubMed ID: 6610070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Construction of human-mouse T cell hybrids that express human T cell-associated surface antigens and allow the chromosomal localization of these antigens.
    van Dongen JJ; Geurts van Kessel AH; Wolvers-Tettero IL; Versnel MA; van Oudenaren A; Schoenmaker E; Hagemeijer A
    J Immunol; 1986 Aug; 137(3):1047-53. PubMed ID: 3487584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Establishment of a human fusion partner for making human T-T hybridomas which can grow in serum free medium.
    Kawahara H; Maeda-Yamamoto M; Hakamata K
    Hum Antibodies; 1999; 9(2):83-7. PubMed ID: 10405828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Secretion of human monoclonal antibody after fusion of an immortal T cell line and lymphocytes from the peripheral blood of a patient with colon carcinoma.
    Dillman SL; Aldenderfer P; Strelkauskas A
    Hum Antibodies Hybridomas; 1994; 5(1-2):32-40. PubMed ID: 7858181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hybrids from fusion of normal human T lymphocytes with immortal human cells exhibit limited life span.
    Pereira-Smith OM; Robetorye S; Ning Y; Orson FM
    J Cell Physiol; 1990 Sep; 144(3):546-9. PubMed ID: 2391382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increase of hybridoma formation by human lymphocytes after stimulation in vitro; effect of antigen, endothelial cells, and PWM.
    Astaldi GC; Wright EP; Willems C; Zeijlemaker WP; Janssen MC
    J Immunol; 1982 Jun; 128(6):2539-42. PubMed ID: 6804563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incorporation of T cell counterparts in the fusion partners for generation of human monoclonal antibodies from Staphylococcus aureus stimulated B lymphocytes.
    Gore MM; Singhania SS; Basu A; Banerjee K
    Hum Antibodies; 1997; 8(1):26-32. PubMed ID: 9265502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumorigenicity of human HT1080 fibrosarcoma X normal fibroblast hybrids: chromosome dosage dependency.
    Benedict WF; Weissman BE; Mark C; Stanbridge EJ
    Cancer Res; 1984 Aug; 44(8):3471-9. PubMed ID: 6744274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Production of bovine immunoregulatory molecules by xenogeneic hybrids.
    Collins RA; Jones BV; Oldham G
    Immunology; 1990 Oct; 71(2):266-70. PubMed ID: 2228027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Production of human-human hybridomas secreting antibody to sheep erythrocytes after in vitro immunization.
    Strike LE; Devens BH; Lundak RL
    J Immunol; 1984 Apr; 132(4):1798-803. PubMed ID: 6699402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human T-T cell hybridomas: development and applications.
    Fox FE; Platsoucas CD
    Hum Antibodies Hybridomas; 1990; 1(1):3-9. PubMed ID: 2103350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human T cell hybridomas producing lymphokines. I. Establishment and characterization of human T cell hybridomas producing lymphotoxin and migration inhibitory factor.
    Kobayashi Y; Asada M; Higuchi M; Osawa T
    J Immunol; 1982 Jun; 128(6):2714-8. PubMed ID: 7042845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid generation of human T cell hybridomas.
    Mayer L; Fu SM; Kunkel HG
    J Immunol Methods; 1985 Aug; 81(2):271-81. PubMed ID: 3874914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of human monoclonal antibodies derived from lymphocytes of patients with cancer.
    Cote RJ; Morrissey DM; Oettgen HF; Old LJ
    Fed Proc; 1984 Jun; 43(9):2465-9. PubMed ID: 6327400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a fusion partner cell line for efficient production of human monoclonal antibodies from peripheral blood lymphocytes.
    Kalantarov GF; Rudchenko SA; Lobel L; Trakht I
    Hum Antibodies; 2002; 11(3):85-96. PubMed ID: 12454369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Production of human suppressor T cell hybridomas.
    Greene WC; Fleisher TA; Nelson DL; Waldmann TA
    J Immunol; 1982 Nov; 129(5):1986-92. PubMed ID: 6214585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human-human B cell hybridomas from in vitro stimulated lymphocytes of patients with common variable immunodeficiency.
    Denis KA; Wall R; Saxon A
    J Immunol; 1983 Nov; 131(5):2273-8. PubMed ID: 6313803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of a human X mouse T cell hybridoma and identification of a clone secreting and binding interleukin-2.
    Durrant LG; Parkar M; Kenworthy N; Taylor GM
    Immunology; 1984 May; 52(1):117-28. PubMed ID: 6609121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A hypotetraploid human T lymphoid cell line established by cell fusion.
    Ishii K; Yodoi J; Hanaoka M; Furuyama JI
    J Cell Physiol; 1978 Jan; 94(1):93-8. PubMed ID: 304066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.